Paroxysmal nocturnal hemoglobinuria (PNH) Registry

Go Back to All Clinical Trials

Paroxysmal nocturnal hemoglobinuria (PNH) Registry

Brief description of study

This is a non interventional registry to gather information on the clinical presentation and outcomes of patients with PNH. The PHN Registry will capture post-marketing data on patients treated with Soliris. It will collect information on the progression of disease on the Soliris treated and untreated PNH population including those patients who discontinue treatment.

Clinical Study Identifier: 11-02227

ClinicalTrials.gov Identifier: NCT01374360

Principal Investigator: David J Araten.

Contact the research team to learn more about this study.

Your Email

Not a valid e-mail address

Please Provide Email Address

First Name

First name is mandatory

Last Name

Your Phone

Please provide phone number

Invalid phone number

Valid phone number

Comments

Send Confirmation of This To Me

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.

Perlmutter Cancer Center

Clinical Trials & Research Studies